Back
Mirum Pharmaceuticals 10K Form
Buy
69
MIRM
Mirum Pharmaceuticals
Last Price:
41.83
Seasonality Move:
33.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MIRM News And Ratings
See the #1 stock for the next 7 days that we like better than MIRM
MIRM Financial Statistics
Sales & Book Value
Annual Sales: | $186.37M |
---|---|
Cash Flow: | $-14.58M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.81 |
Price / Book: | 8.48 |
Profitability
EPS (TTM): | -2.33950 |
---|---|
Net Income (TTM): | $-109.16M |
Gross Margin: | $139.34M |
Return on Equity: | -51.5% |
Return on Assets: | -17.88% |
Mirum Pharmaceuticals Earnings Forecast
Key Mirum Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 4 years for MIRM is 74.76%.
- The Selling, General & Administrative Expenses for MIRM have been equal to 78.27% of Gross Profit Margin.
- The Research & Development expenses have been 55.06% of Revenue.
- The Interest Expense is -9.24% of Operating Income.
- The Net Earning history of MIRM is -87.68% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 3 years.
Mirum Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | MIRM |
CUSIP: | 604749 |
Website: | mirumpharma.com |
Debt
Debt-to-Equity Ratio: | 1.34 |
---|---|
Current Ratio: | 3.28 |
Quick Ratio: | 3.02 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
MIRM Technical Analysis vs Fundamental Analysis
Buy
69
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy or a Sell?
-
Mirum Pharmaceuticals stock is rated a Buy
The current Mirum Pharmaceuticals [MIRM] share price is $40.72. The Score for MIRM is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.